← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,486개
ADCBiologicstaleTORL Biotherapeutics, LLCPhase 1

TORL-2-307-ADC (TORL-2-307-ADC)

Advanced Solid Tumor; Gastric Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleTORL Biotherapeutics, LLCPhase 1

TORL-3-600 (TORL-3-600)

Advanced Solid Tumor; Colorectal Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleNanlin LiPreclinical

trastuzumab (Herceptin, TP Chemotherapy + Trastuzumab)

HER2-positive Breast Cancer · HER2

#HER2#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleNanlin LiPreclinical

trastuzumab (Herceptin, TP Chemotherapy + Trastuzumab + Pertuzumab)

HER2-positive Breast Cancer · HER2

#HER2#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

TPF, radiotherapy and cetuximab (TPF, radiotherapy and cetuximab)

Head and Neck Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleFudan UniversityPhase 2

TQB2102 (TQB2102)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

TQB2868 (TQB2868)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
AntibodystaleChia Tai Tianqing Pharmaceutica…Phase 2

TQB2922 injection+TAS-102 tablets ± Bevacizumab (TQB2922 injection+TAS-102 tablets ± Bevacizumab)

RAS/BRAF Wild Type Colorectal Cancer · RAS/BRAF Wild Type Colorectal Cancer

#RASBRAFWildTypeColorectalCancer#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleRochePreclinical

trastuzumab (Herceptin, TRASTUZUMAB BS)

Gastric Cancer · Gastric Cancer

#GastricCancer#Antibody#Preclinical#항체#면역항체+2
효능 ORR 85.7%임상시험 1상태 ACTIVE
CGTBiologicstaleBellicum Pharmaceuticals, Inc.Phase 1

TROP2-CAR-NK Cells (TROP2-CAR-NK Cells)

Colorectal Cancer; Minimal Residual Disease · TROP2

#TROP2#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

TSLPR-CART (TSLPR-CART)

B-All; Acute Lymphoblastic Leukemia · B-All

#B-All#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
ADCBiologicstaleTubulis GmbHPhase 2

TUB-040 (TUB-040)

Ovarian Cancer; Non-small Cell Lung Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

trastuzumab (TX05, TX05 (trastuzumab))

Breast Cancer; Breast Neoplasms · HER2

#HER2#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 ACTIVE
CGTBiologicstaleHainan Cancer HospitalPhase 1

Targeted CAR-T Cells (Targeted CAR-T Cells)

Advanced Solid Cancers · Advanced Solid Cancers

#AdvancedSolidCancers#CGT#Phase1#세포유전치료#CAR-T+2
효능 ORR 67%임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Targeted therapy with bevacizumab (Targeted therapy with bevacizumab)

Locally Advanced Rectal Cancer (LARC) · Locally Advanced Rectal Cancer (LARC)

#LocallyAdvancedRectalCancerLARC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleFudan UniversityPhase 2

trastuzumab (Herceptin, Taxanes combined with trastuzumab and pertuzumab.)

Advanced HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
효능 ORR 91.8%임상시험 1상태 RECRUITING
AntibodystaleQamar KhanPhase 2

trastuzumab (Herceptin, Taxotere, Carboplatin, Herceptin + Pertuzumab)

HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
CGTBiologicstaleSecond Affiliated Hospital, Sch…Phase 1

Tcrx T cell (Tcrx T cell)

Gastric Cancer; Gastroesophageal-junction Cancer · Gastric Cancer

#GastricCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
AntibodystaleXinqiao Hospital of ChongqingPhase 2

Thalidomide+cetuximab+FOLFOX/FOLFIRI (Thalidomide+cetuximab+FOLFOX/FOLFIRI)

Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer · Thalidomide Enhances Clinical Efficacy o

#ThalidomideEnhancesClinicalEffic#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleTianjin Medical University Canc…Phase 2

Tiselizumab (Tiselizumab)

Follicular Lymphoma · Follicular Lymphoma

#FollicularLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING

65 / 75 페이지

← 이전다음 →